Keeping this in mind, you may want to design your own personal benchmark that measures absolute performance (i.e. performance vs. your investment goals) rather than performance relativeto the market.
Yet another cost the nation has to face, Topol noted in e-mail interview, will be the enormous cost of conducting huge trials to compare the relative benefits of various popular drugs.